Drug intelligence / Profile preview

Sysmoist

Development stage: Unknown
Lead developer: Soviet
Modality: Small Molecules
Administration: Ophthalmic

Overview

Sysmoist is an over-the-counter lubricating eye drop developed and marketed by Soviet Pharmaceuticals. It is formulated as an ophthalmic solution containing polyethylene glycol 400 (0.4% w/v) and propylene glycol (0.3% w/v). Sysmoist is indicated for the temporary relief of burning, irritation, and discomfort associated with dry eyes or exposure to environmental elements such as wind and sun. It functions as an artificial tear, mimicking the natural tear film to lubricate, hydrate, and protect the ocular surface.

Brand names: SysmoistSysmoist Ultra
Other names: polyethylene glycol 400 + propylene glycol

Beyond the preview

Go deeper on Sysmoist.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sysmoist.

Explore the full profile